St. Petersburg State Pavlov Medical University

This study aims to improve outcomes for patients with high-risk blood cancers who receive a stem cell transplant from a partially matched donor. Researchers are testing a modified combination of two drugs (bendamustine and cyclophosphamide) given after the transplant. The goal is…

This study is comparing two different first-line treatment approaches for advanced Hodgkin lymphoma. One group receives a newer combination of immunotherapy (nivolumab) with chemotherapy (AVD), while the other receives standard chemotherapy regimens. The main goal is to see if th…